Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-10T09:07:13.375Z Has data issue: false hasContentIssue false
  • English
  • Français

Ibuprofen and indomethacin differentially regulate vascular endothelial growth factor and its receptors in ductus arteriosus endothelial cells

Published online by Cambridge University Press:  04 December 2017

Hannes Sallmon ,
Sandra Akanbi ,
Sven C. Weber ,
Alexander Gratopp ,
Cornelia Rheinländer  and
Petra Koehne
Hannes Sallmon*
Affiliation:
Department of Neonatology, Charité University Medical Center, Berlin, Germany
Sandra Akanbi
Affiliation:
Department of Neonatology, Charité University Medical Center, Berlin, Germany
Sven C. Weber
Affiliation:
Department of Pediatrics/Neonatology and Pediatric Intensive Care Medicine, University of Greifswald, Greifswald, Germany
Alexander Gratopp
Affiliation:
Division of Pediatric Emergency and Intensive Care Medicine, Charité University Medical Center, Berlin, Germany
Cornelia Rheinländer
Affiliation:
Department of Neonatology, Charité University Medical Center, Berlin, Germany
Petra Koehne
Affiliation:
Department of Neonatology, Charité University Medical Center, Berlin, Germany
*
Correspondence to: H. Sallmon, MD, Department of Neonatology, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. Tel: +49 450 566 122; Fax: +49 450 566 922; E-mail: hannes.sallmon@charite.de
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Cyclooxygenase inhibitors are widely applied to facilitate ductal closure in preterm infants. The mechanisms that lead to patent ductus arteriosus closure are incompletely understood. Vascular endothelial growth factor plays pivotal roles during ductal closure and remodelling.

Aim

The aim of this study was to investigate the effects of ibuprofen and indomethacin on the expression of vascular endothelial growth factor and its receptors in a primary rat ductus arteriosus endothelial cell culture.

Methods

Protein expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 1 and 2 was confirmed in rat ductus arteriosus and aorta by immunofluorescence staining. Fetal rat endothelial cells were isolated from ductus arteriosus and aorta using immunomagnetic cell sorting and treated with ibuprofen or indomethacin. mRNA expression levels were assessed by quantitative polymerase chain reaction analysis.

Results

In ductal endothelial cells, ibuprofen significantly induced vascular endothelial growth factor and its receptor 2, but not receptor 1, whereas indomethacin did not alter the expression levels of the vascular endothelial growth factor system. In contrast, ibuprofen significantly induced vascular endothelial growth factor and its receptors 1 and 2 in aortic endothelial cells, whereas indomethacin only induced vascular endothelial growth factor receptor 2.

Conclusion

Our results indicate differential effects of ibuprofen and indomethacin on the expression levels of the vascular endothelial growth factor system in ductus arteriosus endothelial cells. In addition, vessel-specific differences between ductal and aortic endothelial cells were found. Further in vivo studies are needed to elucidate the biological significance of these findings.

Keywords

Ductus arteriosusendothelial cellibuprofenindomethacinVEGF
Type
Original Articles
Information
Cardiology in the Young , Volume 28 , Issue 3 , March 2018 , pp. 432 - 437
Check for updates
Copyright
© Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Hamrick, SE, Hansmann, G. Patent ductus arteriosus of the preterm infant. Pediatrics 2010; 125: 1020–1030.Google Scholar
2. Sallmon, H, Koehne, P, Hansmann, G. Recent advances in the treatment of preterm newborn infants with patent ductus arteriosus. Clin Perinatol 2016; 43: 113–129.Google Scholar
3. Clyman, RI, Seidner, SR, Kajino, H, et al. VEGF regulates remodeling during permanent anatomic closure of the ductus arteriosus. Am J Physiol Regul Integr Comp Physiol 2002; 282: R199–R206.Google Scholar
4. Weber, SC, Rheinlaender, C, Sarioglu, N, et al. The expression of VEGF and its receptors in the human ductus arteriosus. Pediatr Res 2008; 64: 340–345.Google Scholar
5. Echtler, K, Stark, K, Lorenz, M, et al. Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med 2010; 16: 75–82.Google Scholar
6. Sallmon, H, Weber, SC, Hüning, B, et al. Thrombocytopenia in the first 24 hours after birth and incidence of patent ductus arteriosus. Pediatrics 2012; 130: e623–e630.CrossRefGoogle ScholarPubMed
7. Weber, SC, Gratopp, A, Akanbi, S, et al. Isolation and culture of fibroblasts, vascular smooth muscle, and endothelial cells from the fetal rat ductus arteriosus. Pediatr Res 2011; 70: 236–241.Google Scholar
8. Liu, Y, Cox, SR, Morita, T, Kourembanas, S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5’ enhancer. Circ Res 1995; 77: 638–643.Google Scholar
9. Christou, H, Yoshida, A, Arthur, V, et al. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol 1998; 18: 768–776.Google Scholar
10. Waleh, N, Seidner, S, McCurnin, D, et al. Anatomic closure of the premature patent ductus arteriosus: The role of CD14+/CD163+ mononuclear cells and VEGF in neointimal mound formation. Pediatr Res 2011; 70: 332–338.Google Scholar
11. Beharry, KD, Modanlou, HD, Hasan, J, et al. Comparative effects of early postnatal ibuprofen and indomethacin on VEGF, IGF-I, and GH during rat ocular development. Invest Ophthalmol Vis Sci 2006; 47: 3036–3043.Google Scholar
12. Heuchan, AM, Clyman, RI. Managing the patent ductus arteriosus: current treatment options. Arch Dis Child Fetal Neonatal Ed 2014; 99: F431–F436.Google Scholar
13. Weber, SC, Weiss, K, Bührer, C, Hansmann, G, Koehne, P, Sallmon, H. Natural history of patent ductus arteriosus in very low birth weight infants after discharge. J Pediatr 2015; 167: 1149–1151.Google Scholar
14. Reese, J, Laughon, MM. The patent ductus arteriosus problem: infants who still need treatment. J Pediatr 2015; 167: 954–956.Google Scholar
15. Liebowitz, M, Clyman, RI. Prophylactic indomethacin compared with delayed conservative management of the patent ductus arteriosus in extremely preterm infants: effects on neonatal outcomes. J Pediatr 2017; 189: 13–17.Google Scholar
16. Barikbin, P, Sallmon, H, Wilitzki, S, et al. Lung function in very low birth weight infants after pharmacological and surgical treatment of patent ductus arteriosus – a retrospective analysis. BMC Pediatr 2017; 17: 5.Google Scholar
17. Weisz, DE, Mirea, L, Rosenberg, E, et al. Association of patent ductus arteriosus ligation with death or neurodevelopmental impairment among extremely preterm infants. JAMA Pediatr 2017; 171: 443–449.Google Scholar
18. Ment, LR, Peterson, BS, Meltzer, JA, et al. A functional magnetic resonance imaging study of the long-term influences of early indomethacin exposure on language processing in the brains of prematurely born children. Pediatrics 2006; 118: 961–970.Google Scholar
19. Kim, SY, Shin, SH, Kim, HS, et al. Pulmonary arterial hypertension after ibuprofen treatment for patent ductus arteriosus in very low birth weight infants. J Pediatr 2016; 179: 49–53.e1.Google Scholar
20. Voelkel, NF, Vandivier, RW, Tuder, RM. Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 2006; 290: L209–L221.Google Scholar